Treat to target? Efficacy of insulin use in patients with Type 2 diabetes (T2DM) in a secondary care setting

被引:0
|
作者
Muraleedharan, V. [1 ]
Caddick, L. [1 ]
Hardisty, C. [1 ]
Tesfaye, S. [1 ]
Scott, A. [1 ]
机构
[1] Royal Hallamshire Hosp, Dept Diabet, Sheffield S10 2JF, S Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:75 / 75
页数:1
相关论文
共 50 条
  • [31] Adiponectin as a Predictor of T2dm in the Asymptomatic Offspring of Patients with Type 2 Diabetes
    Anwar, Muhammad Jawad
    Sajjad, Ayesha
    Jawad, Madiha
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (04): : 1316 - 1317
  • [32] Exercise Training Counterbalance 'Side-Effects' of the Insulin Therapy in Patients with Type 2 Diabetes (T2DM)
    Balducci, Stefano
    Zanuso, Silvano
    Fallucca, Sara
    Cardelli, Patrizia
    Cavallo, Stefano
    Fernando, Fredrick
    Alessi, Elena
    Fallucca, Francesco
    Pugliese, Giuseppe
    DIABETES, 2010, 59 : A626 - A626
  • [33] Patients with type 2 diabetes (T2DM) have defective hepatic autoregulation
    Chen, XH
    Iqbal, N
    Boden, G
    DIABETES, 1999, 48 : A295 - A295
  • [34] PHYSICIAN'S AND PATIENT'S PERCEPTIONS AND BELIEFS REGARDING INSULIN INITIATION AND USE IN PATIENTS WITH TYPE 2 DIABETES (T2DM) IN CHINA
    Liu, L. L.
    Babineaux, S. M.
    Kadziola, Z.
    Brnabic, A. J.
    Luo, T.
    VALUE IN HEALTH, 2012, 15 (07) : A664 - A665
  • [35] Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in patients with type 2 diabetes mellitus (T2DM)
    Miyazaki, Y
    Mahankali, A
    Matsuda, M
    Mahankali, S
    Cusi, K
    Mandarino, L
    Defronzo, RA
    DIABETES, 2000, 49 : A299 - A299
  • [36] SPECIAL EFFECTS OF INSULIN REGIMEN (DISSIMILAR PROCEDURES) ON HOSPITALIZED PATIENTS OF TYPE 2 DIABETES MELLITUS (T2DM)
    Ahmad, Shakeel
    Kanwal, Samra
    Haider, Muhammad Haroon
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (08): : 8180 - +
  • [37] Efficacy of low dose sibutramine in obese type-2 diabetes mellitus (T2DM) Indian patients
    Gupta, Ashwani K.
    Badyal, Dinesh K.
    Matreja, Prithpal S.
    Khosla, Prem P.
    John, Mary
    WORLD FAMILY MEDICINE, 2012, 10 (03): : 29 - 35
  • [38] Vildagliptin versus voglibose monotherapy in patients with type 2 diabetes (T2DM): Superior efficacy and tolerability with vildagliptin
    Iwamoto, Yasuhiko
    Kashiwagi, Atsunori
    Yamada, Nobuhiro
    Terao, Shinji
    Suzuki, Manabu
    DIABETES, 2008, 57 : A167 - A167
  • [39] Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes (T2DM) and mild hyperglycemia
    Scherbaum, W. A.
    Schweizer, A.
    Mari, A.
    Nilsson, P. M.
    Lalanne, G.
    Jauffret, S.
    Foley, J. E.
    DIABETES, 2007, 56 : A134 - A134
  • [40] A randomized, double-blind, placebo controlled study of the efficacy and safety of inhaled Technosphere® insulin in patients with type 2 diabetes (T2DM)
    Rosenstock, J
    Baughman, RA
    Rivera-Schaub, T
    Otterbach, K
    Donigi-Gale, D
    Thibault, J
    Tomiak, M
    Shang, KN
    Boss, AH
    Cheatham, WW
    DIABETES, 2005, 54 : A88 - A88